東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

Challenges and solutions against visceral leishmaniasis

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Challenges and solutions against visceral leishmaniasis/ edited by Angamuthu Selvapandiyan ... [et al.].
其他作者:	Selvapandiyan, Angamuthu.
出版者:	Singapore :Springer Nature Singapore : : 2023.,
面頁冊數:	xxi, 449 p. :ill. (some col.), digital ;24 cm.
內容註:	Module 1_Epidemiology and Surveillances -- Module 2_Omics and Advancement in Diagnosis -- Module 3_Genetics -- Module 4_New Drug Discovery Opportunity -- Module 5_Immunity and Vaccine Development.
Contained By:	Springer Nature eBook
標題:	Kala-azar. -
電子資源:	https://doi.org/10.1007/978-981-99-6999-9
ISBN:	9789819969999

Challenges and solutions against visceral leishmaniasis
Challenges and solutions against visceral leishmaniasis[electronic resource] /edited by Angamuthu Selvapandiyan ... [et al.]. - Singapore :Springer Nature Singapore :2023. - xxi, 449 p. :ill. (some col.), digital ;24 cm.

Module 1_Epidemiology and Surveillances -- Module 2_Omics and Advancement in Diagnosis -- Module 3_Genetics -- Module 4_New Drug Discovery Opportunity -- Module 5_Immunity and Vaccine Development.

This book comprehensively reviews the epidemiology and surveillance strategies of Visceral Leishmaniasis, and the latest developments in disease diagnosis, drug discovery, and vaccine development. The initial chapters cover the epidemiology features and spatial distribution of Visceral Leishmaniasis. The book further discusses the manifestations of HIV-Visceral Leishmaniasis infection on the immunopathogenesis, diagnosis, and therapeutic response. It analyzes the role of different proteomic technologies in understanding the parasite development, survival, drug resistance mechanisms, host-pathogen interactions, and the development of new therapeutic approaches. The book concludes by discussing recent advancements in vaccine development for Visceral Leishmaniasis. It discusses the promising vaccine candidate, their developmental status, current challenges, and prospects for rational vaccine development against Leishmania. This book is an invaluable source of information for students, and researchers working to understand the Leishmania biology, and drug development.

ISBN: 9789819969999

Standard No.: 10.1007/978-981-99-6999-9doiSubjects--Topical Terms:

3672263
Kala-azar.

LC Class. No.: RC152

Dewey Class. No.: 616.9364

Challenges and solutions against visceral leishmaniasis
LDR:02276nmm a2200325 a 4500 001 2337354
003 DE-He213
005 20240127073637.0
006 m d
007 cr nn 008maaau
008 240523s2023 si s 0 eng d
020 $a 9789819969999 $q (electronic bk.)
020 $a 9789819969982 $q (paper)
024 7 $a 10.1007/978-981-99-6999-9 $2 doi
035 $a 978-981-99-6999-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC152
072 7 $a PSGH $2 bicssc
072 7 $a MED103000 $2 bisacsh
072 7 $a PSG $2 thema
082 0 4 $a 616.9364 $2 23
090 $a RC152 $b .C437 2023
245 0 0 $a Challenges and solutions against visceral leishmaniasis $h [electronic resource] / $c edited by Angamuthu Selvapandiyan ... [et al.].
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2023.
300 $a xxi, 449 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Module 1_Epidemiology and Surveillances -- Module 2_Omics and Advancement in Diagnosis -- Module 3_Genetics -- Module 4_New Drug Discovery Opportunity -- Module 5_Immunity and Vaccine Development.
520 $a This book comprehensively reviews the epidemiology and surveillance strategies of Visceral Leishmaniasis, and the latest developments in disease diagnosis, drug discovery, and vaccine development. The initial chapters cover the epidemiology features and spatial distribution of Visceral Leishmaniasis. The book further discusses the manifestations of HIV-Visceral Leishmaniasis infection on the immunopathogenesis, diagnosis, and therapeutic response. It analyzes the role of different proteomic technologies in understanding the parasite development, survival, drug resistance mechanisms, host-pathogen interactions, and the development of new therapeutic approaches. The book concludes by discussing recent advancements in vaccine development for Visceral Leishmaniasis. It discusses the promising vaccine candidate, their developmental status, current challenges, and prospects for rational vaccine development against Leishmania. This book is an invaluable source of information for students, and researchers working to understand the Leishmania biology, and drug development.
650 0 $a Kala-azar. $3 3672263
650 0 $a Kala-azar $x Diagnosis. $3 3672264
650 0 $a Kala-azar $x Treatment. $3 3672265
650 1 4 $a Parasitology. $3 635062
650 2 4 $a Structure-Based Drug Design. $3 3538435
650 2 4 $a Pharmaceutics. $3 3538434
650 2 4 $a Epidemiology. $3 568544
700 1 $a Selvapandiyan, Angamuthu. $3 3672262
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-99-6999-9
950 $a Medicine (SpringerNature-11650)